Save your place

Sign in to WhoBought

Please try again later.

Neurocrine Biosciences, Inc. (NBIX) institutional ownership

Latest close $176.41 Jul 27, 2026
Market cap$12.8B 52-week range SectorHealthcare
Funds holding · Q1 2026
700
reported NBIX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
375 buyers · 325 sellers

Neurocrine Biosciences, Inc. (NBIX) price and institutional activity

Dates

Q1 2026

$0 bought by 375 investors
Two Sigma Investments, LPAQR Capital Management LLC +373 more
$0 sold by 325 investors
T. Rowe Price AssociatesBellevue Group AG +323 more
Bought Sold Totals per quarter; hover a bar for the names.

Neurocrine Biosciences, Inc. (NBIX) institutional activity · 700

Investor Type Est. change Change Δ Own Date
Two Sigma Investments, LP · Added
Change +2.1M Δ Own +210.8% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +2.1M +210.8% Q1 2026
T. Rowe Price Associates · Reduced
Change −1.7M Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −1.7M Q1 2026
Bellevue Group AG · Reduced
Change −1.7M Date Q1 2026
Bellevue Group AG Reduced· Q1 2026 −1.7M Q1 2026
AQR Capital Management LLC · Added
Change +1.7M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +1.7M Q1 2026
Vestal Point Capital, LP · New
Change +1.2M Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +1.2M Q1 2026
Norges · Exited
Change −1.1M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −1.1M −100.0% Q1 2026
Los Angeles Capital Management LLC · Reduced
Change −1.1M Date Q1 2026
Los Angeles Capital Management LLC Reduced· Q1 2026 −1.1M Q1 2026
Two Sigma Advisers, LP · Exited
Change −843K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −843K −100.0% Q1 2026
Millennium Management LLC · Added
Change +805K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +805K Q1 2026
Victory Capital Management Inc · Added
Change +607K Date Q1 2026
Victory Capital Management Inc Added· Q1 2026 +607K Q1 2026
Deerfield Management Company, L.P. · Reduced
Change −574K Date Q1 2026
Deerfield Management Company, L.P. Reduced· Q1 2026 −574K Q1 2026
BlackRock · Added
Change +555K Date Q1 2026
BlackRock Added· Q1 2026 +555K Q1 2026
Jacobs Levy Equity Management, Inc · Added
Change +485K Date Q1 2026
Jacobs Levy Equity Management, Inc Added· Q1 2026 +485K Q1 2026
First Trust Advisors LP · Added
Change +472K Date Q1 2026
First Trust Advisors LP Added· Q1 2026 +472K Q1 2026
Zurich Insurance Group Ltd · Exited
Change −459K Δ Own −100.0% Date Q1 2026
Zurich Insurance Group Ltd Exited· Q1 2026 −459K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 700

Famous investor activity in Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences, Inc. (NBIX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Delaet Ingrid · Officer Sell −$791K
Price $181.02 Qty −4K Owned 16K ΔOwn −21.2% Trade date Jul 10, 2026 Filed date Jul 13, 2026
Delaet Ingrid Officer Sell $181.02 −4K −$791K 16K −21.2% Jul 10, 2026 Jul 13, 2026
Delaet Ingrid · Officer 2 operations 0
Price $106.02 Owned 0 Trade date Jul 10, 2026 Filed date Jul 13, 2026
Delaet Ingrid Officer 2 operations $106.02 0 0 Jul 10, 2026 Jul 13, 2026
Lippoldt Darin · Officer Sell −$1.8M
Price $179.60 Qty −10K Owned 55K ΔOwn −15.4% Trade date Jul 9, 2026 Filed date Jul 13, 2026
Lippoldt Darin Officer Sell $179.60 −10K −$1.8M 55K −15.4% Jul 9, 2026 Jul 13, 2026
Lippoldt Darin · Officer 2 operations 0
Price $81.49 Owned 5K Trade date Jul 9, 2026 Filed date Jul 13, 2026
Lippoldt Darin Officer 2 operations $81.49 0 5K Jul 9, 2026 Jul 13, 2026
Delaet Ingrid · Officer Sell −$1.5M
Price $178.72 Qty −8K Owned 16K ΔOwn −34.2% Trade date Jul 9, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer Sell $178.72 −8K −$1.5M 16K −34.2% Jul 9, 2026 Jul 9, 2026
Delaet Ingrid · Officer 2 operations 0
Price $103.52 Owned 7K Trade date Jul 9, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer 2 operations $103.52 0 7K Jul 9, 2026 Jul 9, 2026
Delaet Ingrid · Officer Sell −$489K
Price $178.54 Qty −3K Owned 16K ΔOwn −14.4% Trade date Jul 8, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer Sell $178.54 −3K −$489K 16K −14.4% Jul 8, 2026 Jul 9, 2026
Delaet Ingrid · Officer 2 operations 0
Price $103.52 Owned 16K Trade date Jul 8, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer 2 operations $103.52 0 16K Jul 8, 2026 Jul 9, 2026
Delaet Ingrid · Officer Sell −$607K
Price $178.57 Qty −3K Owned 16K ΔOwn −17.3% Trade date Jul 7, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer Sell $178.57 −3K −$607K 16K −17.3% Jul 7, 2026 Jul 9, 2026
Delaet Ingrid · Officer 2 operations 0
Price $103.52 Owned 19K Trade date Jul 7, 2026 Filed date Jul 9, 2026
Delaet Ingrid Officer 2 operations $103.52 0 19K Jul 7, 2026 Jul 9, 2026
Lippoldt Darin · Officer 2 operations −$1.7M
Price $170.03–$170.81 Qty −10K Owned 55K Trade date Jun 29, 2026 Filed date Jun 30, 2026
Lippoldt Darin Officer 2 operations $170.03–$170.81 −10K −$1.7M 55K Jun 29, 2026 Jun 30, 2026
Lippoldt Darin · Officer 4 operations 0
Price $81.49 Owned 15K Trade date Jun 29, 2026 Filed date Jun 30, 2026
Lippoldt Darin Officer 4 operations $81.49 0 15K Jun 29, 2026 Jun 30, 2026
Lippoldt Darin · Officer Sell −$34K
Price $169.56 Qty −200 Owned 55K ΔOwn −0.4% Trade date Jun 26, 2026 Filed date Jun 30, 2026
Lippoldt Darin Officer Sell $169.56 −200 −$34K 55K −0.4% Jun 26, 2026 Jun 30, 2026
Lippoldt Darin · Officer 2 operations 0
Price $81.49 Owned 25K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Lippoldt Darin Officer 2 operations $81.49 0 25K Jun 26, 2026 Jun 30, 2026
Sherwin Stephen A. · Director 5 operations −$4.1M
Price $163.81–$167.31 Qty −25K Owned 16K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Sherwin Stephen A. Director 5 operations $163.81–$167.31 −25K −$4.1M 16K Jun 5, 2026 Jun 9, 2026
15 of 94
15 of 94 Sign in to continue to older insider transactions.

Neurocrine Biosciences, Inc. (NBIX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 13.6M
% of shares outstanding 13.9% Filing date Jan 23, 2024
BlackRock Inc. 13.6M 13.9% Jan 23, 2024
Vanguard Group Inc 9.7M
% of shares outstanding 9.9% Filing date Feb 13, 2024
Vanguard Group Inc 9.7M 9.9% Feb 13, 2024
JPMorgan Chase & Co. 6.3M
% of shares outstanding 6.3% Filing date Jul 27, 2026
JPMorgan Chase & Co. 6.3M 6.3% Jul 27, 2026
Vanguard Capital Management 5.3M
% of shares outstanding 5.2% Filing date Apr 30, 2026
Vanguard Capital Management 5.3M 5.2% Apr 30, 2026
State Street Corp 5.1M
% of shares outstanding 5.1% Filing date Oct 17, 2024
State Street Corp 5.1M 5.1% Oct 17, 2024
T. Rowe Price Associates 4.4M
% of shares outstanding 4.5% Filing date Feb 14, 2022
T. Rowe Price Associates 4.4M 4.5% Feb 14, 2022
FMR LLC 3.8M
% of shares outstanding 4.0% Filing date Aug 10, 2021
FMR LLC 3.8M 4.0% Aug 10, 2021
Janus Henderson Group PLC 2.4M
% of shares outstanding 2.5% Filing date Feb 9, 2023
Janus Henderson Group PLC 2.4M 2.5% Feb 9, 2023
8 of 8

Neurocrine Biosciences, Inc. (NBIX) ownership FAQ

Who owns NBIX?

700 reporting institutions disclosed NBIX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.